Pimavanserin safety in adult and elderly patients with neuropsychiatric symptoms related to neurodegenerative disease: An open-label extension study.
Saved in:
| Title: | Pimavanserin safety in adult and elderly patients with neuropsychiatric symptoms related to neurodegenerative disease: An open-label extension study. |
|---|---|
| Authors: | Cubała WJ; Department of Psychiatry, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland., Berrio A; Acadia Pharmaceuticals Inc., San Diego, CA, USA., Chi-Burris K; Acadia Pharmaceuticals Inc., San Diego, CA, USA., Alva G; ATP Clinical Research, Department of Psychiatry and Neuroscience, University of California at Riverside, Riverside, CA, USA., Chrones L; Acadia Pharmaceuticals Inc., Princeton, NJ, USA., Pathak S; Acadia Pharmaceuticals Inc., Princeton, NJ, USA. |
| Source: | Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2025 Jul; Vol. 106 (2), pp. 783-793. Date of Electronic Publication: 2025 Jul 01. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: SAGE Publications Country of Publication: United States NLM ID: 9814863 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-8908 (Electronic) Linking ISSN: 13872877 NLM ISO Abbreviation: J Alzheimers Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1875-8908 |
|---|---|
| DOI: | 10.1177/13872877251345162 |
